Rolando Toyos, M.D. is the Medical Director and Founder of Toyos Clinic. HE is the Inventor of IPL treatment for dry eye. He graduated from Santa Rosa High School. He received his Bachelors and Masters degrees from The University of California, Berkeley and Stanford University, where he was a straight A student.He then received his medical degree at the University of Illinois where he was Class President, graduating with James Scholar Academic Honors and received a community service award for helping Chicago City Public Schools develop a pre-med program for students interested in medicine. He completed his internship in Internal Medicine at Illinois Masonic Hospital in Chicago. He completed his Ophthalmology residency at Northwestern University and Chicago Children's Hospital. Dr. Toyos spent one year performing LASIK at the Assil Eye Institute in Beverly Hills. Dr. Toyos is Board Certified in Ophthalmology and specializes in Cataract Surgery, LASIK, Glaucoma, and Dry Eye. He is one of the most experienced surgeons in the country, completing over 35,000 cataract surgeries, 20,000 glaucoma laser treatments and 25,000 LASIK surgeries. He has won several community awards like, CEO of the Year Inside Memphis Business, The Memphis Business Journal's Top 40 Under 40, Cystic Fibrosis Foundation's Memphis Finest, and Memphis Magazine's Who's Who. Toyos Clinic has been recognized as one the fastest growing companies in the United States by Inc. Magazine.
He is an Optometrist, graduate of La Salle University in Colombia, 1987. Experienced in eye-care business professional into Optical / Ophthalmologic and Optometry industry channels in Latin America with twenty-nine years of clinical, academic and business experience. And he is also Senior Clinical Optometrist and Researcher at Unidad Oftalmológica del Valle in México City. Commercial Director of Yolia Health. Academic Director of the Institute of Continuing Education in Optometry in Mexico. Professor of graduate contact lens fitting post refractive surgery at Universidad Nacional Autonoma de México (UNAM). President and Founder of the Latin American Association of Contact Lens and Cornea. Professional Consultant Vision Care, clinical and business (Bausch + Lomb, Blanchard / Lumilent, Synergeyes and Johnson & Johnson). EC Member OPHTHAMOLOGY editor Academic Program Coordinator 3rd Symposium Contact Lenses, AMFECCO, Mexico City 2016
Optician, University of Buenos Aires, Argentina. Specialist in Contact Lenses. Specialist and manufacturer of ocular prosthesis. Scientific adviser for ocular prosthesis in APO (Asociación Profesional de Optómetras in Argentina). Precursor and creator of multiperforated orbital implant, JUMAT. Precursor and creator of expander orbit asmotic hydrogel filling for microophthalmia. Director of CEPROC. Director of Ocular Prosthesis Division in Perfect Vision, Santiago, Chile. Developer of one-hour customized ocular prosthesis method, unique in Latinamerica. Precursor and creator of the first prosthetic scleral lens.
Luis Carlos Fliguer is the founding director of LENTICON, Argentina. He is also one of the founding member of Latin American Association of Optometry and Optics. He is a Specialties in Low Vision - Contact Lenses - Color Blindness-Capabilities different. He has published various article in national as well as international magazines and has lectured at many conferences, universities, distance learning programs mostly around entire South American Region, Europe and also in North America.
Hudson Nakamura is a Medical Specialist in Ophthalmology and specialized in Retina and Vitreous. He completed his study from School of Medicine at the Federal University of Goiás – UFG and Residency from the Base Hospital of the Federal District - Brasília - DF. Presently, member of American Academy of Ophthalmology, Brazilian Council of Ophthalmology, Canadian Society of Ophthalmology and also the member of most prestigious society ARVO - The Association for Research in Vision and Ophthalmology United States. He working as a Professor in Department of Retina and Vitreous Course of Medical Residency in Ophthalmology at the Bank of Goias Eye Foundation. He also working as Specialist in vitreoretinal disease Fellowship - University of Toronto Canada, Specialist in Ophthalmology - University of Toronto Canada, Specialist in vitreoretinal disease Fellowship - Brazilian Center for Eye Surgery.
Melissa Toyos is a Summa Cum Laude graduate of Louisiana State University who is a board-certified Ophthalmologist. She joins Toyos Clinic from one of the largest practices in the country, Discover Vision Centers in Kansas City, where she was a partner.She has extensive experience in the use of lasers, fillers, botox, latisse, and lid surgery to achieve facial rejuvenation. She is the pioneer of the Mixto Laser Lift, a laser procedure that has won the International Non-Surgical Enhancement Award for the last three years. Many public figures have utilized her skills to look their best. Dr. Toyos is a national researcher and lecturer. She trains other doctors on surgical techniques as well as the use of ocular and cosmetic medications. Her clinical research has been used by the FDA to approve various medications that are now out in the market today. She is a two time award winner of the American Society of Cataract and Refractive Surgery Research Grant. She won the Lieberman Research Award from the American Academy of Ophthalmology (AAO). She has published and edited over 100 publications and is a frequent lecturer at the AAO. She is the Director of Research at Toyos Clinic where she directs several FDA research projects.
He was born in Mexico City February 1981. Completed Medicine in the UNAM National autonomous University of Mexico graduating with high Honors in 2005. He was General Ophthalmology residency in Conde de Valenciana Hospital in Mexico City 2005 to 2009. Subspecialty in Glaucoma in Conde de Valenciana Hospital 2009 to 2010 Subspecialty in Anterior segment microsurgery 2012 to 2013 in Mexico General Hospital High specialty in Ophthalmology research in APEC (association to prevent Blindness in Mexico) 2014 to 2015 Masters in Hospital administration and public health in Institute for public administration 2015 ongoing Partner of Neovision (private Ophthalmology clinic) 2012 ongoing Founder and chief of medicine in Valley Ophthalmology in Mexico City 2010 ongoing Head of research and residency education in Gea Gonzalez General Hospital Mexico City
Born in 1950 in the region of Transylvania, Romania. He Graduated from the Hebrew University – Hadassah Medical School in Jerusalem, Israel in 1974. In 1985 he finished his residency in Ophthalmology, and in 1990 a fellowship in Neuro-Ophthalmology at the University of Michigan in Ann-Arbor, MI, USA. For the last twenty-five years is the head of the Neuro-Ophthalmology service at the Hadassah Medical Center in Jerusalem, Israel. In addition to his longstanding clinical work, he has collaborated internationally with several medical services in research studies, wrote few chapters in medical textbooks, co-authored almost forty articles published in the international medical literature, lectured in many Ophthalmological & Neuro-Ophthalmological conferences and organized tens of courses along the years in Neuro-Ophthalmology in various meetings.
Dr. Naj Sharif is a graduate of Southampton University, England (UK) where he received his BSc (Joint Honors: Biochemistry and Physiology) and his PhD (Neuroscience). Dr. Sharif has been in the pharmaceutical industry for >30-years holding leadership positions of increasing scope and responsibility, spanning Discovery Research, Drug Development and Regulatory Affairs. He has worked at Parke-Davis/Warner-Lambert (Pfizer), Syntex Research (Roche), Alcon-Novartis, and is currently at Santen Inc (Executive Director, R&D Division). Dr. Sharif’s 23-tenure at Alcon resulted in his contributions to the discovery/development and US FDA approvals of Travatan®, Patanol®, Emedine®, Simbrinza®, Izba® and Pazeo® to treat glaucoma/ocular hypertension and ocular allergies. He was recently co-responsible for acquiring Innfocus Inc for Santen, and has thus helped add a device for glaucoma treatment to the product pipeline of Santen. Dr. Sharif was recently elected as a Fellow of ARVO (FARVO), and Fellow of British Pharmacology/Pharmaceutical Society (FBPhS) for his exemplary service on numerous committees, progress on drug discovery, and advancement of scientific reputation of both societies. He was honored as the first recipient of the inaugural Dr. Roger Vogel award for pharmaceutical research presented by the ARVO Foundation (2014), and he just received the “Sir James Black Award” for contributions to drug discovery from BPS (2017). He has been an organizer, chairman and invited Keynote speaker at numerous global conferences, symposia and workshops. Dr. Sharif serves on the editorial boards of numerous scientific journals, is an adjunct Professor at several universities, and a thesis advisor for MS- and PhD-level students. He has published >190 scientific articles and edited 2 Neuroscience books. Dr. Sharif is also the holder of >23 issued US and EU patents on ocular cell-lines and small molecules to treat human diseases of the CNS and the eye. He has interests in discovering, developing and bringing to the market novel drugs (including neuroprotectants) / devices / diagnostic therapeutics to alleviate the symptoms and suffering associated with human ocular and CNS diseases.